In order to investigate the anti‐cancer properties of LCRF‐0006, we initially assessed the effect of LCRF‐0006 treatment on the viability of the N‐cadherin‐expressing mouse MM cell line 5TGM1 in vitro. This evidence concerns the gene CDH2 and Miyoshi myopathy.